Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Am Acad Dermatol. 2016 Aug 9;75(5):889–896. doi: 10.1016/j.jaad.2016.06.061

Table I.

Demographic information and disease characteristics of the 28 participating psoriasis patients

HLA-Cw*0602
Homozygous (n=4) Heterozygous (n=17) Negative (n=7)
Men, n (%) 0 5 (29) 1 (14)
Age, mean years ± SD 32.5 ± 5.9 33.2 ± 11.8 35.1 ± 6.0
Body mass index (kg/m2) ± SD 24.0 ± 1.5 25.6 ± 4.9 23.6 ± 3.4
Age at psoriasis onset, mean years ± SD 14.3 ± 6.9 13.9 ± 6.5 16 ± 7.3
Psoriasis duration, mean years ± SD 18.3 ± 10.1 19.3 ± 9.3 19.1 ± 8.6
Psoriatic arthritis, n (%) 1 (25) 4 (24) 1 (14)
Initial PASI score, mean ± SD 13.5 ± 1.7 12.3 ± 4.9 9.9 ± 3.2
Initial PDI score, mean ± SD 13.3 ± 2.8 12.4 ± 7.2 10.4 ± 6.4
Initial PLSI score, mean ± SD 14.0 ± 1.9 12.0 ± 5.1 12.3 ± 5.5

PASI, Psoriasis Area and Severity Index. PDI, Psoriasis Disability Index. PLSI, Psoriasis Life Stress Inventory.